-
Most Recent
Search Results
240 results for icgn
5 Stephen Hawking Quotes to Remember the Iconic Physicist
Stephen Hawking passed away early on Wednesday morning while at his home in Cambridge and ‘InvestorPlace’ is remembering him with some quotes.
Iconic Luxury Retailer Henri Bendel Closing for Good
Henri Bendel, a luxury retailer based in NYC, is closing its doors for good as owner L Brands (LB) looks to save some money.
Ringling Brothers Circus to Phase Out Iconic Elephants
The Ringling Brothers Circus, announced on Thursday, that it won’t have elephant acts by 2018 as it phases the animals out of its shows.
Can Pat Toomey Save Ocugen (OCGN) Stock?
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen’s advisory board.
The Reasons to Avoid OCGN Stock Keep Piling Up
OCGN stock got a bump on Phase 3 results but was met with market skepticism following its subsequent strategic moves.
3 Iconic American Brands Destined for the Trash Heap
The economic downturn — and in some cases, just good, old-fashioned obsolescence — is taking a toll on these three American mainstays.
How Buffett & 6 Other Icons Fared in 2010
Who had a better year on Wall Street — Warren Buffett, Carl Icahn or Jim Cramer?
Why This Iconic Glass Company Is a Great AI Play
If we were to play a word-association game and I said, “Artificial intelligence,” you might respond with something like “Nvidia,” or “Google.” Maybe even, “Robots.”…
Why This Iconic Glass Company Is a Great AI Play
In yesterday’s Market 360, we talked briefly about entering Phase 2 of the AI Revolution thanks to quantum computing. Today, I want to share a great…
Why Is Ocugen (OCGN) Stock Up 7% Today?
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.
Why Is Ocugen (OCGN) Stock Up 20% Today?
Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.
Why You Should Keep Your Distance from Ocugen Stock
Off and on the price chart OCGN stock, today’s reality is bleak for shareholders, but being a bear poses its own challenges.
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Entry Into Infectious Disease Field Creates Opportunity for Ocugen
Now that Ocugen is collaborating to develop a Covid-19 vaccine, OCGN stock holders should brace for a possible regulatory authorization.
The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat
No one wants to be the bearer of bad news, but we must acknowledge that the vertical move in OCGN stock is turning out to…
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Ocugen Has a Longer Road To Paying off Than People Think
Ocugen seems to have delivered good news in recent days, yet OCGN stock is right back where it started. Does that create a buying opportunity?
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it’s best to avoid OCGN stock.
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely
Biotech Speculators Should Try a Small Position in Ocugen Stock
Probably because it’s not a buzzworthy coronavirus stock, you might not hear much about OCGN stock but it still has strong upside potential.
Icon Energy Fund Offers Commodity Focus to IRA Investors
With top oil stocks like Exxon and Chevron, the Icon Energy Fund is a good way to buy the energy sector and the rise in…
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn’t be applying for a crucial authorization.
The Slide in Ocugen Could Be a Slide to a Homerun
Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin.
3 – 10 of 240 results
